Vectus Biosystems Limited (ASX:VBS)
Australia · Delayed Price · Currency is AUD 0.0830
0.00 (0.00%)
Aug 29, 2025, 3:28 PM AEST
Vectus Biosystems Market Cap
Vectus Biosystems has a market cap or net worth of 4.43 million as of August 29, 2025. Its market cap has decreased by -89.53% in one year.
Market Cap
4.43M
Enterprise Value
3.62M
Revenue
884.21K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since February 23, 2016, Vectus Biosystems's market cap has decreased from 36.22M to 4.43M, a decrease of -87.78%. That is a compound annual growth rate of -19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 4.43M | 7.95% |
| Dec 23, 2024 | 4.10M | -74.31% |
| Dec 29, 2023 | 15.96M | -58.89% |
| Dec 30, 2022 | 38.83M | -15.39% |
| Dec 31, 2021 | 45.89M | 20.81% |
| Dec 31, 2020 | 37.99M | 174.16% |
| Dec 13, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 104.18B |
| Pro Medicus | 31.60B |
| Cochlear | 19.69B |
| Sonic Healthcare | 11.78B |
| Ramsay Health Care | 8.78B |
| Telix Pharmaceuticals | 6.41B |
| Ansell | 5.00B |
| Mesoblast | 3.15B |